What to Expect Your First Month on GLP-1 Medication

Your first month on GLP-1 medication is a transition period. Understanding what’s normal helps you stay the course through the adjustment phase rather than stopping prematurely. Here’s a realistic week-by-week breakdown.

Week 1: The Starting Dose

You’ve taken your first injection at the lowest dose (0.25 mg semaglutide or 2.5 mg tirzepatide). At this dose, the medication is primarily acclimating your body to GLP-1 receptor activation. Weight loss at this stage is minimal — don’t expect dramatic results in week one.

What you might notice: a subtle reduction in appetite, mild nausea (usually 6–24 hours post-injection), slight fullness after smaller meals, and possibly increased thirst. Some patients notice nothing at all at the starting dose. Both responses are normal.

Week 2: Finding Your Rhythm

By the second injection, your body is beginning to adjust. If you experienced nausea after the first dose, it’s typically less intense this week. You may notice more consistent appetite reduction — meals that used to feel necessary feel optional. The “food noise” that many patients describe (constant thoughts about food) may begin to quiet.

Weight loss during weeks 1–2 is typically 1–3 pounds, primarily from reduced food intake rather than the medication’s full metabolic effect, which takes weeks to develop.

Weeks 3–4: Settling In

By the end of the first month, most patients have established a routine: injection day, predictable side effect window (if any), adjusted eating patterns. Common experiences at this stage include smaller portions feeling satisfying, reduced interest in snacking between meals, better awareness of physical hunger versus emotional hunger, and early GI adaptation (less nausea, though constipation may develop).

Total first-month weight loss averages 3–5 pounds. Some patients lose more, some less. The starting dose is sub-therapeutic for weight loss — it exists to build tolerance. The real results come with dose escalation in months 2–4.

What’s Normal vs. What’s Not

Normal: Mild nausea, reduced appetite, slight fatigue, occasional bloating or constipation, injection site redness.

Call your provider: Vomiting that prevents keeping down fluids for 24+ hours, severe abdominal pain (pancreatitis risk), signs of allergic reaction (facial swelling, difficulty breathing), severe diarrhea with dehydration signs.